Regarding other commonly used cancer treatments, such as chemo/radiotherapy or immunotherapy, there are no studies addressing the implications of p38β in response to these treatments, except for the one mentioned above in lung cancer [93], and for thymoquinone, a natural compound, in which its antitumor effect has been related to down regulation of p38β [119]. The gene discussed is MAPK11; the disease is lung carcinoma.